Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance Imaging
Status
Conditions
Treatments
Details and patient eligibility
About
The purpose of this study is to assess degree of hepatic fibrosis using multiparametric MRI for investigating difference between normal or early fibrosis and advanced fibrosis.
Full description
In patients with liver parenchymal disease or normal liver parenchyma who are scheduled to undergo either liver resection or liver biopsy are included.
Referred patients undergo multiparametric MRI including perfusion, diffusion, elastography and fat quantification before surgery or biopsy.
The pathophysiologic changes are evaluated using multiparametric MRI, and compared between normal/early fibrosis and advanced fibrosis.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
- patients who are scheduled to undergo liver resection for focal liver lesion
- patients who are scheduled to undergo liver resection or percutaneous biopsy for diffuse parenchymal disease
- liver donor candidate who are scheduled to undergo preoperative liver biopsy or liver resection
- AND patients/living donor candidates who sign informed consent
Exclusion Criteria: Patients who have at least one of followings are excluded.
- Patients who are contraindication for MRI contrast enhanced MRI.
- Premenopausal female patients who are pregnant.
- Patients who are physically compromised to acquire liver MRI
Trial design
Primary purpose
Allocation
Interventional model
Masking
69 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal